Join
Live feed
·
PRReleasevia Quantisnow
Calidi Biotherapeutics Inc. logo

Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference

ByQuantisnow·Wall Street's wire, on your screen.
CLDI· Calidi Biotherapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLDI (Calidi Biotherapeutics Inc.) and more on Quantisnow.